Johnson MW
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
ArticlePsychedelics
Development of Japanese Versions of the 4-Item Mystical Experience Questionnaire and 7-Item Challenging Experience Questionnaire.
ArticlePsilocybin
Factors Associated with Intentions to Use Psilocybin for Mental Health in Relation to Psychotherapy, Psychiatric Medications, and Natural/Synthetic Options.
ArticlePsilocybin
Psilocybin in the Treatment of Cocaine Use Disorder: A Randomized Clinical Trial.
ArticlePsilocybin
Psilocybin or Nicotine Patch for Smoking Cessation: A Pilot Randomized Clinical Trial.
ArticlePsilocybin
Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions.
ArticlePsilocybin
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE104: A Double-Blind, Randomized, Single Ascending Dose Placebo-Controlled Study.
ArticlePsilocybin
Adverse reactions among psychedelic users: Norwegian validation of the Challenging Experience Questionnaire.
ArticlePsilocybin
Psychedelics and substance use disorder treatment.
ArticlePsilocybin
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.
ArticlePsilocybin
Shame, Guilt and Psychedelic Experience: Results from a Prospective, Longitudinal Survey of Real-World Psilocybin Use.
ArticleMDMA
Psychedelic and MDMA-Related Adverse Effects-A Call for Action.
ArticlePsilocybin
The Mystical Experience Questionnaire 4-Item and Challenging Experience Questionnaire 7-Item.
ArticlePsilocybin
IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models.
ArticlePsilocybin
Beliefs and Perceived Barriers Regarding Psychedelic-assisted Therapy in a Pilot Study of Service Members and Veterans With a History of Traumatic Brain Injury.
ArticlePsilocybin
Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey.
ArticlePsilocybin
Assessing potential of psilocybin for depressive disorders.
ArticlePsychedelics
Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review.
ArticlePsilocybin
Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default.
ArticlePsilocybin
Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.
ArticlePsilocybin
Psychedelic Identity Shift: A Critical Approach to Set And Setting.
ArticlePsilocybin
Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.
ArticlePsilocybin
Human behavioral pharmacology of psychedelics.
ArticleDMT
A narrative synthesis of research with 5-MeO-DMT.
ArticlePsilocybin
Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities.
ArticlePsilocybin
Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives.
ArticlePsilocybin
Psychedelics and health behaviour change.
ArticlePsilocybin
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.
ArticlePsilocybin
Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches.
ArticlePsilocybin
Set and Setting: A Randomized Study of Different Musical Genres in Supporting Psychedelic Therapy.
ArticlePsychedelics
Consciousness, Religion, and Gurus: Pitfalls of Psychedelic Medicine.
ArticlePsychedelics
The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human Brain.
ArticlePsilocybin
Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan.
ArticlePsilocybin
Editorial: Hallucinogens and Entactogens: Establishing a New Class of <i>Psychotherapeutic</i> Drugs?
ArticlePsilocybin
Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey.
ArticlePsilocybin
Cessation and reduction in alcohol consumption and misuse after psychedelic use.
ArticlePsilocybin
Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT.
ArticlePsilocybin
Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.
ArticlePsilocybin
Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.
ArticlePsilocybin
The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.
ArticlePsilocybin
Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences.
ArticlePsilocybin
Potential Therapeutic Effects of Psilocybin.
ArticlePsilocybin
An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.
ArticlePsilocybin
The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.
ArticlePsilocybin
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.
ArticlePsychedelics
Psychedelic medicine: a re-emerging therapeutic paradigm.
ArticlePsilocybin
Psilocybin, psychological distress, and suicidality.
ArticlePsychedelics
Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in Humans.
ArticlePsilocybin
Can psychedelic compounds play a part in drug dependence therapy?
ArticlePsilocybin
Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction.
ArticlePsilocybin
High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.
ArticlePsilocybin